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This paper reviews the relationships between the effects ofglucocorticoids on rat pancreatic
acinar AR42J cell polyamine levels and cellular growth and differentiation. Glucocorticoids
inhibit the growth of AR42J cells. Glucocorticoids either stimulate or inhibit the formation of
polyamines in avariety ofcell types. Cells require polyamines for normal growth. Therefore, we
tested the hypothesis that polyamines mediate the effects of glucocorticoids on AR42J cells.
First, to confirm that AR42J cells required polyamines for growth we examined the effects of
inhibiting ornithine decarboxylase (ODC). ODC is the most important and generally rate-
limiting enzyme in the synthesis of the polyamines. As expected, the ODC inhibitor difluoro-
methylornithine (DFMO) inhibited AR42J cell DNA synthesis, and the addition ofexogenous
putrescine reversed this effect. The levels of growth inhibition by glucocorticoids and DFMO
treatment were similar. Second, we examined the effects of glucocorticoids on ODC. Surpris-
ingly, glucocorticoids increased levels of AR42J cell ODC mRNA, ODC activity, and putres-
cine. Glucocorticoids increased these parameters over a similar time-course as they decreased
DNA synthesis. Analog specificity studies indicated that a glucocorticoid receptor mediated
both the growth inhibitory and ODC stimulatory effects. Dose-response studies indicated,
however, that growth inhibition was more sensitive to dexamethasone (DEX) than were ODC
levels. Therefore, polyamines do not account for the effects of glucocorticoids on AR42J cell
growth. In these cells, glucocorticoids have opposite and independent effects on ODC and
growth.
INTRODUCTION
Polyamines are naturally occurring organic cations. Although they are extensively
studied and known tobe important in a large number ofcellular functions, the actual
physiologic roles of polyamines remain incompletely understood (for reviews, see
[1,2]). That polyamines are required for normal cell growth is indisputable. The
mechanisms involved in polyamine effects on cell growth remain, however, unclear.
The most useful tool for investigating the roles ofpolyamines has been the ornithine
decarboxylase inhibitor difluoromethylornithine (DFMO). Ornithine decarboxylase
(ODC) is the first and rate-limiting enzyme in the synthesis of the polyamines. A
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variety of growth factors and hormones stimulate ODC activity and ODC gene
expression in a manner suggesting a role ingrowth regulation. Induction ofornithine
decarboxylase activity is one ofthe earliest events that occurs duringthe transition of
cells from dormancy to active proliferation [3]. Inhibition ofODCwith DFMO leads
to a depletion of polyamines and blocks proliferation in virtually all cells [1,2]. In a
few tissues, directly increasing polyamines appears to stimulate cell division [4,5],
although this process is not generally the case. Polyamines may be of particular
importance in the regulation ofproliferation in the gastrointestinal mucosa [6].
Polyamines are also thought to play an important role in pancreatic growth
regulation [7]. Stimulation of pancreatic growth in vivo has been shown to stimulate
ODC and lead to increased polyamines [8,9]. Furthermore, inhibition of ODC with
DFMO inhibits normal pancreatic growth [10]. These studies conducted on pancre-
atic growth have, however, been carried out in vivo where the inherent difficulties of
controlling polyamine levels and the complications of secondary effects make it
difficult to establish whether increased ODC activity and polyamines are necessary
or sufficient for stimulating acinar cell growth.
In order to investigate the regulation of pancreatic acinar cell growth in vitro, our
laboratory has made use of rat pancreatic acinar AR42J cells. AR42J cells were
developed from an azoserine-induced pancreatic tumor and are relatively well
differentiated [11]. While AR42J cells are cancer cells and have some obvious
differences from normal pancreatic acinar cells, they serve as a useful model for the
investigation of cellular mechanisms. Our laboratory has investigated the time and
concentration dependence and steroid specificityofdexamethasone (DEX)-induced
growth inhibition [12] and ODC induction [13] in the rat pancreatic acinar AR42J
cell line. We have also analyzed the role of polyamines in the effects of glucocorti-
coids on AR42J cell growth and differentiation [14]. We found that, in AR42J cells,
glucocorticoids have opposite effects on ODC and cell growth. This paper reviews
the data from these AR42J cell studies, presents comparisons, and discusses the
implications ofthis discrepancy.
EFFECTS OF DEXAMETHASONE AND DFMO
ON AR42J CELL GROWTH
An early observation concerning the effects ofglucocorticoids on AR42J cells was
a marked inhibition of cell growth [11]. In further studies, cells cultured in the
presence or absence of dexamethasone showed no significant difference in DNA
content over the course of the first 24 hours [unpublished observation]. After 48
hours, however, the control cultures continued to double, with a doubling time of
34 hours, while the dexamethasone-treated cells were inhibitedby over 95 percent
[12]. Thus, after 48 hours, dexamethasone-inhibited cultures contained approxi-
mately 50 percent ofthe DNAfound in the control cultures (Fig. 1).
The role of polyamines in AR42J cell growth was examined by observing the
effectsofblockingpolyamine productionwith the ODCinhibitordifluoromethylorni-
thine (DFMO) [14]. Total cellular DNA was measured for cells grown in dialyzed
fetal bovine serum and in the presence or absence of DFMO after 48 hours in
culture. Dialysis of the fetal bovine serum was necessary in order to reduce the
normal levels of putrescine. DFMO (5 mM) inhibited AR42J cell growth to a level
similar to that achieved with dexamethasone [14] (Fig. 1) or the combination of
DFMO and dexamethasone [unpublished observation]. Addition to the medium of
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25 FIG. 1. Effects of dexamethasone and DFMO
on AR42J cell growth. Cells were cultured for 48
hourswith orwithout addition ofdexamethasone
(10nM), DFMO(5mM), or DFMO(5mM) with
0 - added putrescine (100 F.M). Cells were then
DEX DFMO DFMO scraped and analyzed for DNA content. Values
are expressed as percentages ofcontrol DNA per
+ culture well and are the means + SEM of three
PUTRESCINE experiments. Adapted from [12] and [14].
exogenous putrescine completely blocked the inhibitory effects of DFMO [14] (Fig.
1). Direct addition ofputrescine had no effect itselfon AR42J cell growth, nor did it
reverse the growth-inhibitory effects ofdexamethasone [unpublished observation].
Thus, the effects ofglucocorticoids and DFMO onAR42J cell growthwere similar
except that the effects of glucocorticoids were not reversed by the addition of
putrescine. This finding was the first evidence that the glucocorticoid-induced
inhibition was unlikely to be accounted forby a decrease in polyamines.
TIME-COURSE OF DEXAMETHASONE EFFECTS ON AR42J CELL
GROWTH AND ODC
The time-course ofdexamethasone-induced decreases inAR42Jcell DNAsynthe-
sis was analyzed by measurement of(3H)-thymidine incorporation [12]. Dexametha-
sone treatment significantly reduced DNA synthesis after six hours. Half-maximal
inhibition occurred after 12 hours of treatment with dexamethasone. Maximal
inhibition occurred after 18 hours of DEX treatment (9.0 ± 1.0 percent ofcontrol).
To determine the effects of glucocorticoids on AR42J cell ODC, changes in the
level of ODC mRNA and activity were measured [13]. Dexamethasone (100 nM)
increased ODC mRNA levels after six hours. Maximal, threefold increases in the
level of ODC mRNA occurred after 12 hours, and ODC mRNA levels returned to
control values after 48 hours [13]. Dexamethasone also increased ODC activity. A
maximal stimulation ofODC activity ofapproximately twofold was observed after 12
hours of dexamethasone treatment [13]. These increases in ODC resulted in a
27-fold increase in AR42J cell content of putrescine four hours after addition to
culture media [14].
A comparison of the time-courses of glucocorticoid effects on DNA synthesis,
ODC activity, and ODC mRNA levels is shown in Fig. 2.
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FIG. 2. Time-course of DEX action on DNA synthesis and
ODC mRNA and activity. (3H)-thymidine incorporation was
assessed over one hour, after prior 10 nM DEX treatment for
the indicated durations. (3H)-thymidine incorporation is ex-
pressed as percentage of control (cpm/p.g DNA). For ODC
measurements, cells were incubated with dexamethasone for
the indicated periods of time, and ODC activity was then
determined in the cell homogenates. Ornithine decarboxylase
mRNA concentrations were quantitated, using slot-blot analy-
sis. All data are expressed as percentages of average control
and are expressed as mean + SEM of three to seven experi-
ments. Adapted from [12,13,14].
DOSE-RESPONSE FOR DEXAMETHASONE EFFECTS ON DNA
SYNTHESIS AND ODC
To establish the dose-dependency ofthe dexamethasone effects on DNA synthesis
and ODC mRNA, AR42J cells were cultured in the presence ofvarious concentra-
tions of dexamethasone and DNA synthesis, and ODC mRNA levels were then
measured [12,13]. Figure 3 compares these dose-response relationships. Inhibition
ofDNA synthesis was half-maximal at 0.5 nM and maximal at 10 nM dexamethasone
[12]. ODC mRNA induction by dexamethasone also occurred in a dose-dependent
manner [13]. AR42J cells were incubated for 12 hourswithvarious concentrations of
dexamethasone; then ODC mRNA concentrations were determined quantitatively
by slot-blot hybridization. Half-maximal effects were seen at 10 nM and maximal
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E 1 / ODC mRNA content on dexamethasone concen-
50 / tODC mRNA w tration. (3H)-thymidine incorporation over one
stimulation hour and ODC mRNA were measured after treat-
/ ,, '1 ment with dexamethasone at the specified concen-
25 trations. Data are presented as percentages of the
maximal response, either inhibition of DNA syn
0 -to 9 -8 7 6 thesis or stimulation of ODC mRNA levels. Each point represents the mean + SEM of three to
Dexamethasone log (M) seven experiments. Adapted from [12] and [13].
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effects occurred at 100 nM dexamethasone [13]. Higher doses ofdexamethasone had
no additional effect on ODC mRNAconcentrations [unpublished observation].
SPECIFICITY OF GLUCOCORTICOID RESPONSE ON AR42J CELL
GROWTH AND ODC
To determine the steroid specificity of the receptor responsible for the actions of
dexamethasone on AR42J cell DNA synthesis, we examined the effectiveness of
various steroids in inhibiting DNA synthesis [12] (Fig. 4). Dexamethasone was the
most potent (half-maximal effect at 0.5 nM), followed by corticosterone (half-
maximal effect at 200 nM) and aldosterone (half-maximal effect at 600 nM). Neither
progesterone nor estradiol significantly inhibited DNA synthesis. These results were
consistent with specific action on the glucocorticoid receptor.
The specificglucocorticoid antagonist RU 38486wasutilized todeterminewhether
the observed effects on ODC mRNA levels were caused by specific interactions
between dexamethasone and the glucocorticoid receptor [13] (Fig. 4B). The antago-
nistbyitselfhad no effects on ODCmRNAconcentrations at afinal concentration of
up to 100 nM (data not shown). When the antagonist was administered simulta-
neously with dexamethasone, however, it blocked the glucocorticoid induction of
ODC gene expression in a dose-dependent manner. Again the data supported the
hypothesis that a glucocorticoid receptor mediates the effects on ODC gene expres-
sion.
DISCUSSION
ODC and polyamines are required for AR42J cell growth, as proven by the ability
of DFMO to block cell growth and the reversibility of this effect by exogenous
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putrescine. The observations reviewed here argue, however, that glucocorticoids
regulate ODC and DNA synthesis independently in AR42J cells. This hypothesis
was indicated not only by the opposing effects of glucocorticoids on the two
processes, but also by the differences in dose-dependency. Dexamethasone inhibi-
tion of DNA synthesis occurred at ten- to twentyfold lower concentration than its
effects on ODC. Our data show that glucocorticoids simultaneously inhibit AR42J
cell growth and stimulate ODCmRNAlevels, activity, and cellular putrescine levels.
This striking separation ofgrowth from ODC activation and putrescine supports the
proposition that ODC and polyamines are not strictlygrowth-related.
A dissociation of polyamine metabolism from proliferation has been previously
reported in Swiss 3T3 cells [15]. Pronase treatment stimulated 3T3 cells' polyamine
synthesis four- to sixfold but did not increase either DNA synthesis or cell number.
In the same study, glucocorticoids led to substantial increases in DNA synthesis and
cell number that were not accompanied by significant increases in the polyamine
parameters.
The liver also shows a separation ofthe effects ofglucocorticoids on ODC and cell
growth. Glucocorticoids lead to a large increase in ODC mRNA [16] and activity
[16,17] in the liver. Glucocorticoids also induce ODC in hepatocytes in primary
culture [18,19]. Glucocorticoids are, however, potent inhibitors ofhepatocyte growth
both in vivo [20,21] and in vitro [22,23]. Furthermore, aswas the case in the 3T3 cells,
stimuli not inducing liver growth were able to increase ODC, and the extent ofODC
stimulation was not necessarily proportional to the rate ofgrowth [24].
Perhaps the best explanation for these discrepancies is that polyamines are also
involved in a number of cellular functions other than growth. For example, poly-
amines are known to be important for protein and RNA synthesis [1,2]. In some
cases, ODC induction appears to correlate more closely with RNA synthesis than
with DNAsynthesis [15]. Glucocorticoids increase the abundance ofroughendoplas-
mic reticulum in AR42J cells [11]. It is possible that this effect involves de novo
synthesis of ribosomes and that polyamines are involved. Polyamines were required
for glucocorticoid induction of amylase activity, but not amylase mRNA in AR42J
cells [14]. This finding indicates that protein synthesis may have a greater sensitivity
to polyamine depletion than RNAsynthesis. Therefore, it is likely that the induction
of ODC by glucocorticoids in AR42J cells is related to changes in protein synthesis.
These data suggest that interpretation of the effects of treatments on ODC and
polyamines must take into account the fact that those parameters may be more
closely linked to protein synthesis than to cell growth.
The mechanisms by which glucocorticoids affect cell growth remain largely un-
known. In some cell types, glucocorticoids are growth-stimulatory [25-28], while in
others glucocorticoids are growth-inhibitory [20-23]. The general mechanisms for
steroid hormone action involve the induction of gene expression by an interaction
between the hormone-receptor complex and DNA enhancer elements, leading to
increased transcription [29]. In some cases, the actions of glucocorticoids are
explained by alterations in the secretion ofautocrine growth factors [30,31]. In other
cases, effects may be due to changes in growth factor receptors. In most cases,
however, the specific genes responsible for growth effects have not been elucidated.
The AR42J cell may prove a valuable model in the search for the genes by which
glucocorticoids inhibit cell growth.
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CONCLUSIONS
Taken together, the data reviewed here suggest that polyamines should not be
viewed as being strictly growth-related. Thus, increases in ODC activity should not
automatically be interpreted as indications of growth stimulation. The AR42J cell
may be a useful model for delineation of some of the non-growth-related roles of
polyamines and for the investigation of the growth-inhibitory effects of glucocorti-
coids.
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